RAT-HEMATO : Return to Work After Malignant Hemopathy

University Hospital, Angers

Status

Not yet enrolling

Conditions

Multiple Myeloma

Lymphoma

Leukemia

Treatments

Other: "Return-to-work after cancer" consultation

Study type

Interventional

Funder types

Other

Identifiers

NCT06262789

49RC23_0011

Details and patient eligibility

About

Return to work (RTW) of patients after cancer treatment has been a topic of growing interest for the past two decades. Advances in cancer care have led to better patient survival, with some cancers considered as chronic or even cured diseases. The return of patients to their "pre-cancer life" can thus become an objective. Indeed, RTW after cancer is associated with improved quality of life for patients in several studies (improved financial status, improved social contacts, return of functional abilities and improved self-esteem). However, many difficulties can interfere with RTW. Many factors have been identified: disease, treatment, patient and occupational factors. The feeling of "return-to-work self-efficacy" is one of the main psychological determinants and its interest has been recently demonstrated in oncology. It corresponds to a cognitive mechanism based on expectations and/or beliefs of an individual about being able to carry out the actions required to achieve a goal, in this case RTW. The majority of studies on RTW concerns solid cancer and are retrospective. Very few studies have focused on hematological malignancies, whose prognosis was, until recently, worse. Moreover, very few interventional studies exist. There is therefore a significant need for prospective studies with appropriate methodological tools to reliably assess the benefit of interventional measures on RTW. The investigators propose to conduct a prospective, comparative, randomized, multicenter study evaluating the impact of an early RTW-consultation in patients who have been treated for a hematological malignancy. The investigators hypothesize that this consultation will improve patients' RTW rates and RTW quality.

Enrollment

264 estimated patients

Sex

All

Ages

18 to 55 years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria :

Patient with hematological malignancy controlled after treatment
Induction/consolidation chemotherapy completed (excluding maintenance therapy)
Patient aged 18 to 55
Patient having worked at least 6 months in the 2 years before diagnosis of hematological malignancy
Patient who has not yet returned to work since diagnosis of hematological malignancy
Signed informed consent form

Exclusion Criteria:

Patient choosing not to return to work
Patient not affiliated to a social security system
Patient with legal guardian or legal trustee
Patient not understanding French
Patient with severe cognitive impairment at diagnosis, incompatible with the study